AIM2 and Stroke: Overall, the implanted multi‐LED array equipped with a 630‐nm wavelength was obviously effective in the acute phase of stroke by attenuating AIM2 inflammasome activation and mediating pyroptosis at the injured site at 7 days post stroke, as schematically demonstrated in Figure 6e.